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Metformin poisoning is a life-threatening condition with a high mortality rate. We present a patient case of metformin poisoning
following intake of 80 g metformin resulting in severe lactate acidosis with a nadir pH of 6.73 and circulatory collapse, successfully
treatedwith addition of prolonged intermittent hemodialysis (HD) to continuous venovenous hemofiltration (CVVH).Thepatient’s
pH became normal 48 hours aftermetformin ingestion during simultaneous CVVH and addition of 22 hours of intermittent HD in
the ICU.The highest metformin level was found to be 991𝜇mol/L (therapeutic range 3.9–23.2 𝜇mol/L).We conclude that in cases of
severemetformin poisoningwith circulatory shock and extreme lactic acidosis, the usual CVVHmodalitymight not efficiently clear
metformin.Therefore, additional prolonged HD should be considered even in the state of cardiovascular collapse with vasopressor
requirement.
1. Introduction
Metformin is widely used and is the most frequently pre-
scribed oral antidiabetic drug of the biguanide family [1].
Metformin inhibits hepatic gluconeogenesis and glycogenol-
ysis and enhances peripheral glucose utilisation in patients
with non-insulin-dependent diabetes [2, 3]. Metformin use is
generally safe and well tolerated. However, lactic acidosis is a
well-known complication to metformin treatment, especially
in intentional overdose or in cases of renal insufficiency.
Metformin poisoning is a life-threatening condition with a
very high mortality rate. With the modern intensive care
treatment, mortality ranges from 50% to 30% [4]. However,
those intentional overdose patients with severe acidosis (pH
less than 6.9) have a mortality rate as high as 83% [5]. We
present a patient case of metformin poisoning following
intake of 80 g metformin resulting in severe lactate acidosis
with a nadir pH of 6.73 and circulatory collapse, successfully
treated with addition of prolonged intermittent hemodialysis
(HD) to continuous venovenous hemofiltration (CVVH).
2. Case Presentation
A54-year-old patient with a bodyweight of 66 kg and amedi-
cal history of anxiety, type 2 diabetes, and previous stroke was
admitted to the local hospital one hour after ingestion of 80
grams of metformin in a suicide attempt. At the Emergency
Department, an aspiration of the gastric content was per-
formed followed by administration of activated charcoal.The
patient developed vomiting and diarrhoea. Arterial blood gas
showed pH 7.33, PaCO
2
4.8 kPa, PaO
2
12.8 kPa, bicarbonate
19.3mmol/L, base deficit 7mmol/L, lactate 5.9mmol/L, and
blood glucose 17.9mmol/L. The patient was transferred to a
university hospital.Three hours after ingestion of metformin,
the metabolic acidosis had deteriorated with serum lactate
8.5mmol/L and pH 7.23. Urgent hemodialysis (HD) was
Hindawi
Case Reports in Critical Care
Volume 2018, Article ID 3868051, 4 pages
https://doi.org/10.1155/2018/3868051
2 Case Reports in Critical Care
CVVH
HD HD HD HDHDHD
0
5
10
15
20
25
30
35
A
rt
er
ia
l b
lo
od
 la
ct
at
e (
m
m
ol
/l)
6.6
6.8
7.0
7.2
7.4
7.6
A
rt
er
ia
l b
lo
od
 p
H
0.0
0.4
0.8
1.2
1.6
N
or
ad
re
na
lin
e (
m
cg
/k
g/
m
in
)
10 20 30 40 50 60 70 80 900
Hours since admission to ICU
Figure 1: Measurements of arterial blood pH (red) and lactate (blue) together with the infusion rate of noradrenaline (green) in the hours
following admission to the intensive care unit (ICU). HD denotes hemodialysis and CVVH continuous venovenous hemofiltration.
performed for 4 hours (h) by the nephrology department
with a blood flow of 150mL/min and a Fresenius FX60
dialyzer (Fresenius, Bad Homburg, Germany) with a surface
area of 1.4m2. During HD, the patient became increasingly
acidotic and circulatory unstable and was admitted to the
intensive care unit (ICU) for circulatory support and continu-
ous CVVH. CVVH (Aquarius, Edwards Lifesciences, Irvine,
USA) was initiated with a blood flow of 300mL/min and
a replacement fluid rate of 2000mL/h (30mL/kg/h) with
35mmol/L bicarbonate inAccusol 35 (BaxterHealthcare Ltd.,
Norfolk, United Kingdom) with 50% of the replacement fluid
infused prefilter and 50% postfilter via a dialysis catheter
placed in the right internal jugular vein. Dialyzer used was
Aquamax HF 12 (Nikkiso, Bellco, Italy) with a surface area
of 1,2m2. Because of filter clotting, CVVH stopped after
one hour. The metabolic acidosis escalated further with a
pH decreasing to 6.73 and a serum lactate above the upper
measuring limit of 30mmol/L (ABL800 Flex, Radiometer,
Copenhagen, Denmark). The patient was less conscious
but managed to hyperventilate to a PaCO
2
of 2.6 kPa and
base deficit of 29mmol/L. He developed severe hypotension,
oliguria, hypothermia with core temperature 32.2∘C, and
hypoglycaemia with a nadir blood glucose of 2.3mmol/L.
Noradrenaline infusion was initiated with increasing dosage
to keep mean arterial pressure above 60mmHg. Bicarbonate
8.4% infusion was continued together with volume substi-
tution with crystalloids. CVVH was restarted after 3 hours.
Active external rewarming with forced-air warming blanket
(Model 30000, 3M Health Care, St. Paul, USA) and maximal
possible temperature of 39∘C on CVVH was used to treat
the hypothermia, but the temperature did not increase.
As the patient’s condition deteriorated, the hemodynamic
instability progressed, cardiac arrhythmias occurred, and
serum lactate remained immeasurably high. Focus Assessed
Transthoracic Echocardiography (FATE) revealed a normal
systolic function of both ventricles.
Because CVVH alone failed to stabilise the patient’s con-
dition and despite of hemodynamic instability and vasopres-
sor requirement (noradrenaline infusion 0.4mcg/kg/min), a
decision was made to start HD simultaneously with CVVH.
An extra dialysis catheter was placed in the left internal
jugular vein and intermittent HD with a blood flow of
300mL/min, Fresenius FX80 dialyzer (Fresenius, Bad Hom-
burg, Germany) with a surface area of 1.8m2, with the highest
possible concentration of bicarbonate buffer of 40mmol/L
on HD machine, was simultaneously performed for 4 h and
repeated for 8 h on the first day. On the second day, HD
was performed twice for 8 h and on the third day for 16.5 h,
while CVVH was continued simultaneously for almost 58 h.
Progression of the acidosis occurred with a drop in pH
whenever HD was paused (Figure 1).
On the second day in the ICU, the patient was intubated
and mechanical ventilation was initiated, because of respira-
tory insufficiency due to increasing PaCO
2
. Only 48 h after
metformin ingestion and 36 h in the ICU with cardiopul-
monary support using very high doses of noradrenaline
infusion (up to 1.4mcg/kg/min) and CVVH combined with
22 h in total of intermittent HD with bicarbonate buffer,
the patient’s pH finally normalized. Serum lactate was still
elevated but decreased very slowly to 2mmol/L on the
third day during the continued treatment with CVVH and
intermittent HD. After 58 h on both CVVH and intermittent
HD, the CVVH was discontinued and the patient remained
on intermittent HD because of acute oliguric renal failure
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until day 15. The patient had an increase of international
normalized ratio (INR) from 1.2 at the day of admission
to a maximal value of 2.0 at day 2. The patient’s condition
improved gradually and he was discharged from the hospital
after 7weeks. At that time, the patient was still nourished via a
percutaneous endoscopic gastrostomy tube due to dysphagia
and used a walker due to polyneuropathy. The patient’s renal
function on discharge was normal.
A metformin plasma concentration, determined by high
pressure liquid chromatography tandem mass spectrometry
(WatersAcquityUPLC,XevoTQ-S), was latermeasured from
the plasma obtained 14 h after poisoning (after 4 h of HD
and one hour of CVVH) and was found to be as high as
991 𝜇mol/L (therapeutic range 3.9–23.2 𝜇mol/L). 48 h after
poisoning, remaining on CVVH and additional 20 hours
of intermittent HD, metformin concentration was reduced
to 327 𝜇mol/L. After additional 8 hours of HD and CVVH,
metformin concentrationwas further reduced to 84.4𝜇mol/L
at 62 h after poisoning.
3. Discussion
Severe metformin poisoning often presents with a profound
lactic acidosis followed by collapse of the cardiovascular
system. Symptoms of metformin poisoning are diffuse with
abdominal pain, nausea, vomiting, hypothermia, decreased
level of consciousness, and circulatory instability leading
to multiorgan failure. The circulatory instability is due to
peripheral vasoplegia as described in many case reports
where low systemic vascular resistance was measured [6].
We observed a clinical picture of a hyperdynamic circulatory
state where FATE revealed normal contractility of the heart
together with severe systemic hypotension. Vasoplegia and
vasodilatation can explain hypothermia, which is a common
symptom of metformin poisoning [6].
Treatment of metformin poisoning is symptomatic and
supportive and there is no antidote available. Typical treat-
ment strategies consist of correcting acidosis with intra-
venous sodiumbicarbonate and decreasing the blood levels of
metformin. Further prevention of gastrointestinal absorption
can be achieved with activated charcoal. In case of renal
insufficiency, renal replacement therapy is the only option for
metformin removal and acidosis correction.
Metformin is readily dialyzable. It is a small molecule
with a molecular weight of 165Da, not protein bound, and
after gastrointestinal absorption it rapidly moves into the
tissue compartment and has a large volume of distribution of
63–276 L (1–5 L/kg) [1]. Lalau et al. previously demonstrated
a biphasic pattern of metformin elimination according to
a two-compartment model. This two-compartment model
suggests that a brief hemodialysis session is not sufficient
in eliminating metformin due to a rebound phenomenon
[7]. These pharmacokinetic properties indicate a need of
prolonged dialysis for metformin elimination. Several case
reports describe favourable outcome after severe metformin
poisoning treated with prolonged intermittent HD. These
reports suggest that prolonged HD (>15 h) is needed and
indicated in patients, who suffer from a severe overdose
and who are able to tolerate HD [2, 8]. In our case, 62 h
after ingestion and with ongoing treatment with CVVH
and additional 32 h of intermittent HD, the metformin level
was still elevated to 84.4𝜇mol/L, emphasizing the need for
prolonged HD in severe metformin overdose.
Usually intermittent HD is poorly tolerated in critically
ill patients with hemodynamic instability [9]. In the ICU
setting CVVH or continuous venovenous hemodiafiltration
(CVVHDF) is used because fluid shifts are less profound
and therefore applicable in hemodynamic unstable patients.
However, these modalities need high ultrafiltration rates
for successful treatment in case of metformin intoxication
[10], but clearance of metformin by continuous venovenous
treatment modalities is still 3-4 times less than clearance
by conventional HD [1, 11]. Panzer reported successful use
of two CVVH machines simultaneously for hemodynami-
cally unstable patient to facilitate high volume CVVH [12].
Friesecke has successfully applied the same approach with
two dialysis catheters and used discontinuous hemofiltration
(highflux) in addition to CVVH for severe circulatory unsta-
ble patient. To our knowledge, the use of intermittent HD in a
patient with metformin poisoning with severe hemodynamic
instability and such dependence on vasopressors is described
only once [13]. However, the placement of two dialysis
catheters in the jugular vein position may theoretically lead
to a recirculation between them, if the tips of the catheters are
placed close to each other.The jugular and femoral placement
of the catheters will eliminate this possibility.
Substitution with bicarbonate in case of lactic acidosis
is controversial as there are concerns that treatment with
bicarbonate can increase intracellular acidosis [14]. However,
bicarbonate treatment is widely used to stabilise metabolic
acidosis in cases of metformin poisoning as described in the
literature. We used high doses of bicarbonate as intravenous
infusion and highest possible concentration of bicarbonate
buffer in the HD machine simultaneously with CVVH with
35mmol/L bicarbonate in the Accusol 35 (Baxter) replace-
ment fluid. We observed worsening of the acidosis and
cardiovascular status when HD was paused and we presume
this deterioration to be due to lack of bicarbonate buffer.
Renal replacement therapy, including conventional HD and
CVVH, offers both theoretical and practical advantages over
bicarbonate infusion. These allow for isovolemic correction
of the metabolic acidosis while removing metformin and
lactate [6].
Recent recommendations for metformin poisoning from
the Extracorporeal Treatments in Poisoning Workgroup
advocate for intermittent HD, but continuous renal replace-
ment therapies may be considered if HD is unavailable
[1]. Initiation of dialysis is suggested in very severe cases,
when lactate concentration is >15mmol/L and pH < 7.0
together with shock or organ failure [1]. In our opinion,
these recommendations are more applicable in situations
of metformin-associated lactic acidosis, as in acute high
dose metformin poisoning the acidosis accelerates very fast
and the patient’s condition deteriorates dramatically with
development of circulatory collapse.
We therefore suggest that in cases of acute high dose
metformin poisoningHD should be initiated earlier than that
stated in the recommendations.
4 Case Reports in Critical Care
4. Conclusion
In cases of severe metformin poisoning with shock and
extreme lactic acidosis usual CVVH modality might not
effectively clear metformin and additional prolonged inter-
mittent HD should be considered instead or together with
CVVH, even in the state of cardiovascular collapse with
vasopressor requirement.
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